Ashley Fedusenko
Hospice and Palliative Medicine · Chattanooga, TNNPI 1861846800
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $361 and has fallen 89.8% since, to $37 in 2025.
Across 38 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$137
- Idorsia Pharmaceuticals US Inc$88
- Merck$65
- Dentsply Sirona Inc$56
- Novartis$54
- Genentech USA, Inc.$53
- plus $262 from 10 others
What the payments were for
- Food & beverage$716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 9 | $137 |
| Idorsia Pharmaceuticals US Inc | 5 | $88 |
| Merck | 3 | $65 |
| Dentsply Sirona Inc | 1 | $56 |
| Novartis | 3 | $54 |
| Genentech USA, Inc. | 3 | $53 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Johnson & Johnson | 1 | $34 |
| Neurocrine Biosciences, Inc. | 2 | $32 |
| Seagen Inc. | 2 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Medtronic | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Novo Nordisk | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Amgen | 1 | $15 |
How this compares
$716 in reported general payments places this provider in the 85th percentile of 34 hospice and palliative medicine providers in Tennessee.
See all hospice and palliative medicine providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 44 | $26,112 |
| LinzessLinaclotide | 17 | $10,292 |
| Buprenorphine | 24 | $5,440 |
| Oxycodone Hcl | 131 | $3,959 |
| Dronabinol | 20 | $3,678 |
| Fentanyl | 24 | $3,502 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 89 | $3,333 |
| Naloxone Hcl | 46 | $2,769 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $2,587 |
| Ondansetron Hcl | 22 | $2,185 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $1,112 |
| Pregabalin | 44 | $1,085 |
| Duloxetine Hcl | 52 | $823 |
| Gabapentin | 85 | $770 |
| Morphine Sulfate | 16 | $732 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $137 | $26,11244 claims |
| Lilly USA, LLCOlanzapine | $28 | $56830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 34 hospice and palliative medicine providers in Tennessee.
Other hospice and palliative medicine in Chattanooga
- Maribeth BosshardtChattanooga$586
- Joshua HornsbyChattanooga$19
- Mira PatelChattanooga$18
- William JacksonGermantown$93K
- Barton SandersNashville$4K
- Debra LyonsColumbia$3K
- Sandhya MudumbiNashville$2K
- Melody CunninghamMemphis$2K
- Gina WaltonMemphis$620
- Christina Macmurdo-FranceNashville$518
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.